This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Drug Delivery Remove Genomics Remove Packaging Related Topics
Contract Packaging Packaging Genome In-Vivo Gene Editing Gene Licensing Gene Therapy FDA Approval Medicine More Related Topics >
article thumbnail

Start-up aims to advance transformative genetic medicines

Drug Discovery World

FEBRUARY 16, 2023

The company’s protein nanoparticle (PNP) genetic medicine delivery platform is based on the discovery of endogenous, human proteins derived from retroelements that can self-assemble to form capsid-like structures and which can package and transfer nucleic acid cargo.

Genetics 52
Genetics Medicine Gene Editing In-Vivo 52
article thumbnail

Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’

The Pharma Data

MAY 5, 2021

New variant-hardy AbCellera-Lilly mAb shows utility of viral genomics surveillance ( BioCentury ). Esker, a new biotech startup, launches with plans to make targeted immune drugs ( BioPharma Dive ). Microneedles are promising devices for painless drug delivery with minimal side effects ( EurekAlert ).

Vaccination 52
Vaccination Vaccine Gene Therapy Contract Packaging 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024